Structure activity relationship of plumbagin in BRCA1 related cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structure activity relationship of plumbagin in BRCA1 related cancer cells

Published:2012-01-30 Issue:5 Volume:52 Page:392-403
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

K.A. Thasni,T. Ratheeshkumar,G. Rojini,K.C. Sivakumar,Nair Rakesh Sathish,G. Srinivas,Banerji Asoke,Somasundaram Veena,Srinivas Priya

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference36 articles.

1. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature,2005

2. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005

3. The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors;De Soto;Int J Biol Sci,2006

4. Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells;Srinivas;Mol Carcinog,2004

5. Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents;Thasni;Ann Oncol,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Insights and Pharmaceutical Relevance of Plumbagin in Parasitic Disorders: A Comprehensive Review;Recent Advances in Anti-Infective Drug Discovery;2022-11

2. Interleukin-35 inhibits angiogenesis through T helper17/ Interleukin-17 related signaling pathways in IL-1β-stimulated SW1353 cells;Molecular Immunology;2022-07

3. Plumbagin: A potential candidate for future research and development;Current Pharmaceutical Biotechnology;2021-12-30

4. Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation;Molecular Biology Reports;2020-05-22

5. Isoniazid–phytochemical conjugation: A new approach for potent and less toxic anti‐TB drug development;Chemical Biology & Drug Design;2020-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3